Antioxidant and anti-inflammatory agents in chronic liver diseases: Molecular mechanisms and therapy

doi:10.4254/wjh.v15.i2.180

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 15, Issue 2

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (4101)

All Articles published online

The chart showing PDF series, WORD series, HTML series, Figures (1-3) series, Tables (1-2) series.

Item

Count

PDF

242

WORD

HTML

2691

Figures (1-3)

295

Tables (1-2)

264

Sum=3549

Publishing Process of This Article

The chart showing Browse series, Download series.

Item

Count

Browse

189

Download

363

Sum=552

Feb 27, 2023 (publication date) through May 11, 2024

Times Cited of This Article

Times Cited (16)

Journal Information of This Article

Publication Name

World Journal of Hepatology

ISSN

1948-5182

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Review

World J Hepatol. Feb 27, 2023; 15(2): 180-200
Published online Feb 27, 2023. doi: 10.4254/wjh.v15.i2.180

Full Size Figure Download Figure

Figure 3 Structures of peroxisome proliferator-activated receptor agonists or modulators applied for the treatment of chronic liver disease. Many peroxisome proliferator-activated receptor regulators have been evaluated in the clinic, showing promising effects in patients with chronic liver disease. All the chemical structures were collected online from the Chemical Book (https://www.chemicalbook.com, accessed on August 10, 2022). PPAR: Peroxisome proliferator-activated receptor.

Citation: Zhang CY, Liu S, Yang M. Antioxidant and anti-inflammatory agents in chronic liver diseases: Molecular mechanisms and therapy. World J Hepatol 2023; 15(2): 180-200
URL: https://www.wjgnet.com/1948-5182/full/v15/i2/180.htm
DOI: https://dx.doi.org/10.4254/wjh.v15.i2.180